calendar
3,667 catalysts · 3,321 8k filing · 575 earnings · 129 phase 2 completion · 61 phase 1 completion · 32 phase 1 initiation · 28 phase 1 2 completion
3,667 catalysts · 3,321 8k filing · 575 earnings · 129 phase 2 completion · 61 phase 1 completion · 32 phase 1 initiation · 28 phase 1 2 completion
Items: 1.01, 2.03, 3.02, 9.01
Items: 1.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 1.01, 5.08, 9.01
Items: 8.01, 9.01
Items: 5.02
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 8.01, 9.01
Items: 1.01, 2.03, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 5.07, 9.01
Items: 2.02, 9.01
Items: 4.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02, 9.01
Items: 5.03, 9.01
Items: 5.07, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 3.01, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 5.02, 9.01
Items: 8.01
Items: 5.02
Items: 1.01, 7.01, 9.01
Items: 5.02
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 7.01, 9.01